(Mcap 23 M) Many Approvals coming this year.. FLOAT 1.5 M

[BiotechMaster]

Dehaier is a fantastic Investment for the near and long term .The Company is profitable and cash flow positive and has very very low float of 1.5 million .DHRM awaiting several product approvals in USA and EU in 2011 .

Super low float + Upcoming approvals will bring this massive undervalued stock (P/E 4.8) to 20$++ in no time . Competiters like MR or CMED have a P/E of 20 !!!

DHRM is a real unknown gem IPO was last year at $8 . Time to load up the cheap shares before it gets discovered .GLTA


Dehaier Medical (DHRM)

Market Cap: 23 M
Cash : 6 M
Price : 5.30 $

Shares Out: 4.5 M ..( 3 M shares held by CEO+Insiders )
Low Float : 1.5 M


Fundamental Data
(Nasdaq: DHRM) Dehaier Medical Systems, Ltd.


Analyst Report from March 2011
http://www.dehaier.com.cn/UserFiles/...316_Update.pdf


Company Presentation March 2011
http://www.dehaier.com.cn/UserFiles/...Mar%202011.pdf


CEO letter
Dehaier Medical Chairman and CEO Issues Letter to Shareholders - Yahoo! Finance



International expansion into the US and Europe, where several of our homecare products are currently under review by the Food and Drug Administration (FDA) in the US and Conformite Europeenne (CE) in the European Union.


"2010 was a record year for Dehaier. We achieved strong growth across both our branded and third party medical devices, as well as our homecare products businesses, while positioning the Company for success in 2011 and beyond," said Mr. Ping Chen, CEO of Dehaier. "Key to our growth in 2010 was the continued advancement of our homecare products business, in which we achieved triple-digit gains for both the fourth quarter and full year. While the domestic market presents a compelling growth opportunity, international expansion is a critical element of our longer-term strategy and we are making meaningful progress in this regard, with several of our respiratory therapy homecare products currently pending regulatory approval in the United States and European Union. We believe that securing these approvals and rolling out our products in targeted international markets will provide another important catalyst for our business and help propel Dehaier to the next level of top- and bottom-line growth."

[xaucian]

thx biotechmaster, BUT its -12% premarket ?!

[BiotechMaster]

Yes its down take it as a buying opportunity . DHRM has a very low float thats the reason why the stock is very volatile means it could jump or drop heavily only with a few shares .

The stock is definitely a good investment with all the upcoming Approvals and dont forget the company is profitable .glta

[pignit]

This is a Chinese company. Recently a lot of small cap Chinese companies have fundamental problems/audit frauds. So be careful.

[The Follower]

Resistance is totally inexistant, this stock is ready to rise back to its levels of last week, it just needs to be pushed a bit.

[dawoodasad17]

dear friend
i am new on internet want some help
i visit a website sleek sight dot com its provied me free website but i don't
know to make a designing can any one tell how i can make a free website update and
designing i am very thankful to u for your convinece